08 Nov 2022 BIO INX and Nanoscribe expand their partnership with the launch of HYDROBIO INX© N400, a new biocompatible high resolution bioink enabling live cell encapsulation Member news
08 Nov 2022 New Idylla™ EGFR study shows reduction of time-to-treatment by 48% for lung cancer patients Member news
08 Nov 2022 The QbD Group acquires regulatory affairs and pharmacovigilance company EUDRAC Ltd to expand its services for pharmaceutical customers Member news
04 Nov 2022 Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results Member news
28 Oct 2022 InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model Member news
27 Oct 2022 Indigo Diabetes incorporates fully owned subsidiary in the US and appoints Peter J. Devlin as President, Indigo Medical US Inc. Member news
25 Oct 2022 Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON) Member news
25 Oct 2022 Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation of Medsenic valued at EUR 40 million Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
